跳至主要内容
临床试验/NCT04874519
NCT04874519已完成不适用

Fibrolamellar Carcinoma Global Dynamic Registry

Memorial Sloan Kettering Cancer Center1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2021年11月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
12
试验地点
1
主要终点
Build a Fibrolamellar Cancer/FLC registry

研究概览

简要总结

The purpose of this study is to collect information about people with fibrolamellar cancer (FLC). This study is a registry of people with FLC around the world. This study will involve collecting information about participants, their medical history and the regular medical care they receive for FLC. The study will not provide treatment for your cancer.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
13 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 13 years or older.
  • Personal history of histologically proven fibrolamellar carcinoma (clinical or radiographical suspicion of FLC must be confirmed at MSK or an external hospital)
  • Participants must have access to electronic devices that meet the following minimum requirements:
  • Ability to connect to the internet
  • Capability of running modern internet browers (such as Google Chrome, Internet Explorer, Safari, or Mozilla Firefox).
  • Participants must have a google account

排除标准

  • Participants residing in the European Union (EU).

结局指标

主要结局

Build a Fibrolamellar Cancer/FLC registry

时间窗: 18 months

To build a registry of Fibrolamellar Cancer/FLC through patient reported information, that could be studied further in future studies.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验